WebThe goal of the Mycophenolate REMS is to mitigate the risk of embryofetal toxicity associated with the use of mycophenolate during pregnancy by: Educating healthcare … WebIt is supplied by Mylan Pharmaceuticals Inc. Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants . There is positive evidence of human fetal risk during pregnancy.
Mylan-Mycophenolate · Mylan Pharmaceuticals Ulc · 85 Advance …
WebThe chemical name for mycophenolate mofetil (MMF) is 2-morpholinoethyl (E)-6-(1,3 dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4 hexenoate. … Web13 mei 2024 · Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months … hd 8 fire case
Food and Drug Administration
Web19 jan. 2024 · Warnings. This medicine can cause a miscarriage or birth defects when used during pregnancy. Both men and women should use effective birth control to prevent pregnancy during and shortly after treatment with mycophenolic acid.. Using mycophenolic acid may increase your risk of cancer, serious infections, or kidney … Web28 dec. 2024 · Mycophenolate Mofetil Tablets, USP 500 mg 100 Tablets (10 x 10) Each tablet contains: Mycophenolate mofetil, USP 500 mg Usual Dosage: See accompanying prescribing information and Medication Guide. CAUTION: Special Handling and WebMédicament. Médicament générique. Principe actif. MYCOPHENOLATE MOFETIL MYLAN 250 mg, gélule, boîte de 100. Prescrit pour. Prévention du rejet d'organe après greffe rénale. Prévention du ... hd 8 fire